Deep Tech Startups

Andromede is a reinforcement learning data lab that programmatically generates RL environments, tasks, and verifiers from real-world data for the post-training and evaluation of AI agents. It provides a post-training and evaluation pipeline for long-horizon agent tasks.

1 investor

Andson Biotech develops analytical tools for the analysis of biotherapeutics, aimed at supporting the discovery and development of biologic drugs.

1 investor

AndzonBio operates a suite of thematic "pipeline builder" studios that accelerate the industrial development of academic life sciences projects into biotech companies, focusing on specific therapeutic areas such as cardiovascular/renal/metabolic disorders and neurological disorders. Launched by AdBio Partners and Inserm Transfert, it provides expert support, R&D budgets, and validation to turn academic programs into viable therapeutics companies.

1 investor

Angel Invest is a Super Angel Fund that makes early-stage investments in startups, typically writing €125k first checks and backing companies from pre-incorporation through Angel, Pre-seed, and Seed rounds, mainly in AI, FinTech, and DeepTech. It also coaches founders for at least a year to help them reach product-market fit and raise a Series A, primarily across Europe.

1 investor

AngenMed develops neoantigen-targeting cell-based cancer immunotherapies, including dendritic cell vaccines and neoantigen-specific T cell products personalized to each patient's tumor mutations. The company operates in the biotech and cancer therapeutics space, using tumor sequencing to identify neoantigens and manufacture DC and T-cell products.

1 investor

Animation Inc. builds a proprietary on-device AI model (Ani-2) that generates full-body 3D motion in real time to drive lifelike virtual characters and enrich LLM-based interactions. Its products include an animation engine, a content production engine for generating videos, and Anichat, a platform for creating and interacting with customizable characters.

1 investor

Ankyra Therapeutics is a biopharmaceutical company developing drugs, with a team that has collectively contributed to bringing seven drugs to global market approval.

1 investor

Anofa provides geospatial analytics and GIS solutions for disaster and climate risk assessment, including flood risk, earthquake loss estimation, social vulnerability analysis, and post-disaster recovery. It transforms satellite imagery and spatial data into maps, dashboards, and models for clients focused on risk and resilience.

1 investor

Anokiwave is a fabless semiconductor company that designs highly integrated millimeter-wave silicon ICs used to build phased array active antennas. Its products serve 5G, SATCOM, and defense and aerospace markets, and the company was acquired by Qorvo in 2024.

1 investor

ANRis is a drug discovery venture developing siRNA nucleic acid therapeutics based on the University of Tokyo's "SNPD-siRNA" technology, which selectively suppresses mRNA carrying single-nucleotide variants. It targets driver-gene mutations to create treatments for cancer, genetic disorders, and other diseases.

1 investor

AnserBio develops an oncology biotherapy that restores functional p53 tumor suppressor protein by delivering it through proprietary cell-derived nanovesicles (exosomes). It targets p53-mutant cancers with high unmet need, including colon, bladder, ovarian cancer, and glioblastoma.

1 investor

Ansys provides engineering simulation software used by engineers and students to design and test products. Its tools cover simulation across areas from silicon to systems.

1 investor

AntalGenics is a biotechnology company that discovers and develops active molecules for biomedical and dermocosmetic applications, focusing on sensory neurobiology, peripheral mechanisms, and topical treatments. It also acts as an intermediary between academic research and industry, offering tailored R&D projects and licensing molecules and technologies.

1 investor

Antares Ventures is a venture capital firm that invests in science- and engineering-led deep tech companies at seed to Series B stages and supports their commercial deployment across Asia. It takes board roles, works with founders, and connects portfolio companies to industrial and corporate partners in markets such as Southeast Asia, the Middle East, and Australia.

1 investor

Antennaware develops BodyWave antenna technology that overcomes body blocking in wireless wearables, generating electromagnetic waves that flow around the human body to maintain reliable connections across Sub-GHz, 1.9 GHz, 2.4 GHz, and UWB frequencies. It also offers design-in antenna consultancy and testing services for system design engineers building wireless wearable products.

1 investor

Antenova designs and supplies embedded antennas and RF solutions, offering over 70 off-the-shelf flex PCB and surface-mount SMD antennas plus custom design, integration, and RF testing services. It serves engineers building IoT, M2M, and connected wireless devices.

1 investor

Anthriq builds biosignal infrastructure for human-aware technology, including a 13-channel wireless EEG headset ("Instinct") and an integrated ecosystem of hardware, software, and data for capturing signals such as EEG, ECG, and EMG. It serves researchers, developers, neurotech innovators, and enterprises building applications on top of biosignal data.

1 investor

Antigma builds Ante, a Rust-based agent runtime that runs AI coding agents locally through a single self-contained binary with built-in llama.cpp integration for offline model inference. It supports bring-your-own API keys across providers such as Anthropic, OpenAI, Gemini, and Grok, and is designed to orchestrate large numbers of lightweight "cellular-native" agent replicas.

1 investor

Anyo Labs develops machine learning models grounded in chemistry to accelerate pharmaceutical drug discovery, using in silico screening to identify preclinical candidates and address challenging drug targets. The company works on designing novel, life-saving treatments in the drug discovery field.

1 investor

Anyon Systems designs, builds, and deploys full-stack superconducting quantum computing systems, including hardware and processor-to-application software, for HPC centers, government, universities, and strategic partners. Based in Montréal, the company serves Canadian research and defense institutions and is delivering its Hudson quantum computer enclosure to Defence R&D Canada in 2026.

1 investor

Apeiron Therapeutics is a biotech company developing small-molecule therapeutics with a focus on immuno-oncology and oncology drug discovery. The company operates across the Chinese and global healthcare markets, spanning target identification, medicinal chemistry, and clinical development.

1 investor

Aperture is a vertically integrated technology company that builds low-frequency radar satellite payloads and a soil moisture insights platform. It offers space-based environmental monitoring and daily soil moisture analytics for agriculture, defense, and corporate sustainability clients, supporting irrigation decisions, water stewardship reporting, and landscape restoration.

1 investor

Aperture is a national forensic and technical consulting firm that provides expert analysis, accident reconstruction, and litigation dispute support. It serves legal and business clients by investigating incidents and operational events using forensic methodologies and technology.

1 investor

Apex (株式会社アペックス) is a prototyping and product development contractor founded in 1975, producing design mockups, working models, 3D modeling, mechanical and optical design, GUI/HMI development, electronic control boards, and machining/molding services. It supports research and product development of mechatronics products for industries including home appliances, office equipment, automotive parts, medical devices, and amusement machines.

1 investor